Targeting the tumor vasculature: enhancing antitumor efficacy through combination treatment with ZD6126 and ZD6474.
作者:
主题词
动物(Animals);抗肿瘤药(Antineoplastic Agents);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);癌(Carcinoma);细胞系, 肿瘤(Cell Line, Tumor);结直肠肿瘤(Colorectal Neoplasms);药物评价, 临床前(Drug Evaluation, Preclinical);内皮, 血管(Endothelium, Vascular);女(雌)性(Female);HT29细胞(HT29 Cells);人类(Humans);小鼠(Mice);小鼠, 裸(Mice, Nude);坏死(Necrosis);肿瘤移植(Neoplasm Transplantation);新生血管化, 病理性(Neovascularization, Pathologic);有机磷化合物(Organophosphorus Compounds);卵巢肿瘤(Ovarian Neoplasms);哌啶类(Piperidines);喹唑啉类(Quinazolines);存活率分析(Survival Analysis);时间因素(Time Factors);移植, 异种(Transplantation, Heterologous);肿瘤负荷(Tumor Burden)
PMID
16277020
发布时间
2022-03-25
- 浏览4
In vivo (Athens, Greece)
1045-50页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文